Literature DB >> 23082879

Occipitotemporal hippocampal depth electrodes in intracranial epilepsy monitoring: safety and utility.

Kimon Bekelis1, Atman Desai, Alex Kotlyar, Vijay Thadani, Barbara C Jobst, Krzysztof Bujarski, Terrance M Darcey, David W Roberts.   

Abstract

OBJECT: Intracranial monitoring for epilepsy has been proven to enhance diagnostic accuracy and provide localizing information for surgical treatment of intractable seizures. The authors investigated the usefulness of hippocampal depth electrodes in the era of more advanced imaging techniques.
METHODS: Between 1988 and 2010, 100 patients underwent occipitotemporal hippocampal depth electrode (OHDE) implantation as part of invasive seizure monitoring, and their charts were retrospectively reviewed. The authors' technique involved the stereotactically guided (using the Leksell model G frame) implantation of a 12-contact depth electrode directed along the long axis of the hippocampus, through an occipital twist drill hole.
RESULTS: Of the 100 patients (mean age 35.0 years [range 13-58 years], 51% male) who underwent intracranial investigation, 84 underwent resection of the seizure focus. Magnetic resonance imaging revealed mesial temporal sclerosis (MTS) in 27% of patients, showed abnormal findings without MTS in 55% of patients, and showed normal findings in 18% of patients. One patient developed a small asymptomatic occipital hemorrhage around the electrode tract. The use of OHDEs enabled epilepsy resection in 45.7% of patients who eventually underwent standard or selective temporal lobe resection. The hippocampal formation was spared during surgery because data obtained from the depth electrodes showed no or only secondary involvement in 14% of patients with preoperative temporal localization. The use of OHDEs prevented resections in 12% of patients with radiographic evidence of MTS. Eighty-three percent of patients who underwent resection had Engel Class I (68%) or II (15%) outcome at 2 years of follow-up.
CONCLUSIONS: The use of OHDEs for intracranial epilepsy monitoring has a favorable risk profile, and in the authors' experience it proved to be a valuable component of intracranial investigation. The use of OHDEs can provide the sole evidence for resection of some epileptogenic foci and can also result in hippocampal sparing or prevent likely unsuccessful resection in other patients.

Entities:  

Mesh:

Year:  2012        PMID: 23082879     DOI: 10.3171/2012.9.JNS112221

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Hippocampal gamma-slow oscillation coupling in macaques during sedation and sleep.

Authors:  Andrew G Richardson; Xilin Liu; Pauline K Weigand; Eric D Hudgins; Joel M Stein; Sandhitsu R Das; Alexander Proekt; Max B Kelz; Milin Zhang; Jan Van der Spiegel; Timothy H Lucas
Journal:  Hippocampus       Date:  2017-07-12       Impact factor: 3.899

Review 2.  Evolution of patients with surgically treated drug-resistant occipital lobe epilepsy.

Authors:  Pablo Barbero Aznarez; Marta Pastor Cabeza; Ana Sofia Alvarez Quintana; Monica Lara-Almunia; Julio Albisua Sanchez
Journal:  Surg Neurol Int       Date:  2020-08-01

3.  Extraventricular long-axis cannulation of the hippocampus: technical considerations.

Authors:  Chengyuan Wu; Michael J LaRiviere; Nealen Laxpati; James J Evans; Robert E Gross; Ashwini D Sharan
Journal:  Neurosurgery       Date:  2014-06       Impact factor: 4.654

4.  Safety profile of intracranial electrode implantation for video-EEG recordings in drug-resistant focal epilepsy.

Authors:  Bertrand Mathon; Stéphane Clemenceau; Dominique Hasboun; Marie-Odile Habert; Hayat Belaid; Vi-Huong Nguyen-Michel; Virginie Lambrecq; Vincent Navarro; Sophie Dupont; Michel Baulac; Philippe Cornu; Claude Adam
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

5.  Complications to invasive epilepsy surgery workup with subdural and depth electrodes: a prospective population-based observational study.

Authors:  Emelie Hedegärd; Johan Bjellvi; Anna Edelvik; Bertil Rydenhag; Roland Flink; Kristina Malmgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-11-29       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.